The global market for biotech crops will continue to be fractured unless international approvals are harmonized. It took more than two years for Syngenta to receive European Union approval for the Agrisure Viptera trait in corn, but hurdles remain in other countries, China in particular. Each nation has its own unique scientific and political institutions and constituency concerns to respect, but there is a need for more consistent policies on biotechnology.
View the original article here: International approvals slow for biotech crops
